PhoreMost is a new-model drug discovery company based in Cambridge, UK:

Using its core expertise to open up new ‘druggable’ target space and working with a global network of co-invested academic and industrial collaboration partners, we aim to bring a wide array of novel ‘targeted’ therapies more efficiently to market and pass these cost savings onto patients.

 

‘Golden Goose – Golden Egg’

We are pursuing a ‘Golden Goose – Golden Egg’ business model whereby exciting, well-validated, drug discovery assets derived from our SITESEEKER platform are progressed within asset centric spin-out companies. This model, in working with our collaborative partners maximises both shareholder return, and the ability of PhoreMost’s platform to ultimately yield new medicines across a range of therapeutic areas.